In This Section
Ashwin Chandar, MD
Assistant Professor, Medicine

- About Me
-
Clinical Interests
- Multiple myeloma
- Lymphoma
- Benign hematology
Research Interests
- Health outcomes and quality improvement research in the area of multiple myeloma
- Education, Training & Credentials
-
Educational Background
- Fellowship, Hematology/Oncology, Cancer Institute of New Jersey, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ
- Residency, Internal Medicine, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ
- MD, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ
Certifications
- Internal Medicine
Memberships
- American Society of Hematology
- American Society of Clinical Oncology
Honors & Awards
- Chief Fellow, Rutgers-RWJMS, 2018-19
- Outstanding Fellow Award for Teaching, Rutgers-RWJMS, 2017
- Publications
-
Digital Bibliography
Chandar A, Silk AW, Clark J, Daniels GA, McDermott D, Morse M, Wong M, Stein M, Mehnert J, Danish S, Aung S and Kaufman HL. “Efficacy and Safety of High-Dose Interleukin-2 Treatment in Patients with a History of Brain Metastases from Melanoma”. Journal of Targeted Therapies, published online July 11, 2016